MSCI Inc. Form 8-K Summary
Business Context and Reporting Period
MSCI Inc. filed this Current Report on Form 8-K on June 9, 2022, to disclose the entry into a material definitive agreement. The company is incorporated in Delaware and its common stock trades on the New York Stock Exchange under the symbol MSCI.
Key Financial Metrics and Debt Structure
The filing details the execution of an Amended and Restated Credit Agreement with the following terms:
- Revolving Credit Facility: $500.0 million in commitments available until February 2027 (undrawn at closing).
- Term Loan Facility: $350.0 million in commitments, drawn in full on June 9, 2022, maturing in February 2027.
- Interest Rates: Variable rates based on SOFR or Base Rate plus an applicable margin. Initial margins are 2.00% for SOFR loans and 1.00% for Base Rate loans, subject to adjustment based on the Consolidated Leverage Ratio.
- Amortization: Quarterly installments commence October 15, 2022.
- Expected Impact: Incremental interest expense of approximately $9 million for fiscal year 2022.
Material Changes and Covenants
This agreement amends and restates the existing Revolving Credit Agreement dated November 20, 2014. The new facility introduces specific financial covenants:
- Maximum Consolidated Leverage Ratio: Not to exceed 4.25:1.00 (or 4.50:1.00 for two fiscal quarters following a material acquisition).
- Minimum Consolidated Interest Coverage Ratio: At least 4.00:1.00.
- Restrictions: Covenants restrict subsidiaries from incurring additional indebtedness, creating liens, engaging in sale/leaseback transactions, or mergers without compliance.
Use of Proceeds and Outlook
Proceeds from the $350.0 million term loan will be used for general corporate purposes, including potential share repurchases, investments, and acquisitions. The filing does not provide updated revenue, profit, or cash flow guidance, nor does it disclose specific risks beyond standard credit agreement covenants.
Key Facts for Investor Verification
- Verify the company's current Consolidated Leverage Ratio to ensure compliance with the new 4.25:1.00 covenant.
- Confirm the impact of the $9 million incremental interest expense on fiscal year 2022 earnings.
- Monitor the utilization of the $500.0 million revolving facility for potential liquidity needs or acquisitions.
- Review the full text of Exhibit 10.1 for specific definitions of "Consolidated Leverage Ratio" and "Consolidated Interest Coverage Ratio."